These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 21466750)

  • 61. Cannabis use in children and adolescents with first episode psychosis: influence on psychopathology and short-term outcome (CAFEPS study).
    Baeza I; Graell M; Moreno D; Castro-Fornieles J; Parellada M; González-Pinto A; Payá B; Soutullo C; de la Serna E; Arango C
    Schizophr Res; 2009 Sep; 113(2-3):129-37. PubMed ID: 19427172
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cannabis use and vulnerability for psychosis in early adolescence--a TRAILS study.
    Griffith-Lendering MF; Wigman JT; Prince van Leeuwen A; Huijbregts SC; Huizink AC; Ormel J; Verhulst FC; van Os J; Swaab H; Vollebergh WA
    Addiction; 2013 Apr; 108(4):733-40. PubMed ID: 23216690
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Evidence that environmental and genetic risks for psychotic disorder may operate by impacting on connections between core symptoms of perceptual alteration and delusional ideation.
    Smeets F; Lataster T; Viechtbauer W; Delespaul P;
    Schizophr Bull; 2015 May; 41(3):687-97. PubMed ID: 25217481
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Cannabis use and psychosis: re-visiting the role of childhood trauma.
    Houston JE; Murphy J; Shevlin M; Adamson G
    Psychol Med; 2011 Nov; 41(11):2339-48. PubMed ID: 21557896
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A multi-center, randomized controlled trial of a group psychological intervention for psychosis with comorbid cannabis dependence over the early course of illness.
    Madigan K; Brennan D; Lawlor E; Turner N; Kinsella A; O'Connor JJ; Russell V; Waddington JL; O'Callaghan E
    Schizophr Res; 2013 Jan; 143(1):138-42. PubMed ID: 23187069
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cannabis use and psychosis: a longitudinal population-based study.
    van Os J; Bak M; Hanssen M; Bijl RV; de Graaf R; Verdoux H
    Am J Epidemiol; 2002 Aug; 156(4):319-27. PubMed ID: 12181101
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Understanding cannabis use in first-episode psychosis: an application of the Theory of Planned Behaviour.
    Hames A; Evangeli M; Harrop C; di Forti M
    Early Interv Psychiatry; 2012 Feb; 6(1):38-44. PubMed ID: 22168625
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Long-term risk factors for substance-induced and primary psychosis after release from prison. A longitudinal study of substance users.
    Rognli EB; Berge J; Håkansson A; Bramness JG
    Schizophr Res; 2015 Oct; 168(1-2):185-90. PubMed ID: 26359848
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Change in cannabis use in the general population: a longitudinal study on the impact on psychotic experiences.
    van Gastel WA; Vreeker A; Schubart CD; MacCabe JH; Kahn RS; Boks MP
    Schizophr Res; 2014 Aug; 157(1-3):266-70. PubMed ID: 24930951
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Interaction between environmental and familial affective risk impacts psychosis admixture in states of affective dysregulation.
    Radhakrishnan R; Guloksuz S; Ten Have M; de Graaf R; van Dorsselaer S; Gunther N; Rauschenberg C; Reininghaus U; Pries LK; Bak M; van Os J
    Psychol Med; 2019 Aug; 49(11):1879-1889. PubMed ID: 30284529
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Diagnostic and symptomatological features in chronic psychotic patients according to cannabis use status.
    Maremmani I; Lazzeri A; Pacini M; Lovrecic M; Placidi GF; Perugi G
    J Psychoactive Drugs; 2004 Jun; 36(2):235-41. PubMed ID: 15369205
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Schizophrenia and the city: A review of literature and prospective study of psychosis and urbanicity in Ireland.
    Kelly BD; O'Callaghan E; Waddington JL; Feeney L; Browne S; Scully PJ; Clarke M; Quinn JF; McTigue O; Morgan MG; Kinsella A; Larkin C
    Schizophr Res; 2010 Jan; 116(1):75-89. PubMed ID: 19897342
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Is psychotic disorder associated with increased levels of craving for cannabis? An Experience Sampling study.
    Kuepper R; Oorschot M; Myin-Germeys I; Smits M; van Os J; Henquet C
    Acta Psychiatr Scand; 2013 Dec; 128(6):448-56. PubMed ID: 23330571
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Pre-morbid Conduct Disorder symptoms are associated with cannabis use among individuals with a first episode of psychosis.
    Malcolm CP; Picchioni MM; DiForti M; Sugranyes G; Cooke E; Joseph C; McQueen G; Paparelli A; Stilo S; O'Connor J; Morgan C; Murray RM; Hodgins S
    Schizophr Res; 2011 Mar; 126(1-3):81-6. PubMed ID: 21186097
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Longitudinal assessment of the effect of cannabis use on hospital readmission rates in early psychosis: A 6-year follow-up in an inpatient cohort.
    Colizzi M; Burnett N; Costa R; De Agostini M; Griffin J; Bhattacharyya S
    Psychiatry Res; 2018 Oct; 268():381-387. PubMed ID: 30121541
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Cannabis abuse as a risk factor for depressive symptoms.
    Bovasso GB
    Am J Psychiatry; 2001 Dec; 158(12):2033-7. PubMed ID: 11729021
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Association between age at onset of psychosis and age at onset of cannabis use in non-affective psychosis.
    Galvez-Buccollini JA; Proal AC; Tomaselli V; Trachtenberg M; Coconcea C; Chun J; Manschreck T; Fleming J; Delisi LE
    Schizophr Res; 2012 Aug; 139(1-3):157-60. PubMed ID: 22727454
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Cannabis use at a young age is associated with psychotic experiences.
    Schubart CD; van Gastel WA; Breetvelt EJ; Beetz SL; Ophoff RA; Sommer IE; Kahn RS; Boks MP
    Psychol Med; 2011 Jun; 41(6):1301-10. PubMed ID: 20925969
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Specialized psychosocial treatment plus treatment as usual (TAU) versus TAU for patients with cannabis use disorder and psychosis: the CapOpus randomized trial.
    Hjorthøj CR; Fohlmann A; Larsen AM; Gluud C; Arendt M; Nordentoft M
    Psychol Med; 2013 Jul; 43(7):1499-510. PubMed ID: 23040144
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Is cannabis use a contributory cause of psychosis?
    Degenhardt L; Hall W
    Can J Psychiatry; 2006 Aug; 51(9):556-65. PubMed ID: 17007222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.